Largest pharmaceutical companies by cash on hand
Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.
Johnson & Johnson leads the 61 pharmaceutical companies ranked by cash on hand, at PLN 79.2B, ahead of Merck & Co (PLN 58.6B) and Novartis (PLN 46B). Figures as of 19 Nov 2026, 00:41 UTC, from Yahoo Finance quotes.
Key facts
- Companies ranked
- 61
- First
- Johnson & JohnsonPLN 79.2B
- Median
- PLN 2.3B
- Combined market value
- PLN 20.34T
- Countries
- 10
Market values as of .
All countries▾
All sectors▾
Pharmaceuticals▾
| # | Company | Cash on hand ↓ | Market cap | Price | Today | 1 year | Price, 30 days | Country |
|---|---|---|---|---|---|---|---|---|
| 1 | Johnson & JohnsonJNJ · Health Care | PLN 79.2B | PLN 2.64T | PLN 1,096.43 | 2.15% down | 38% up | ||
| 2 | Merck & CoMRK · Health Care | PLN 58.6B | PLN 1.37T | PLN 553.97 | 3.90% down | 51% up | ||
| 3 | NovartisNVS · Health Care | PLN 46B | PLN 1.18T | PLN 624.05 | 2.46% down | 25% up | ||
| 4 | Bristol-Myers SquibbBMY · Health Care | PLN 41B | PLN 489.5B | PLN 239.47 | 2.92% down | 34% up | ||
| 5 | Abbott LaboratoriesABT · Health Care | PLN 34.3B | PLN 727.5B | PLN 420.08 | 0.22% down | 17% down | ||
| 6 | SanofiSNY · Health Care | PLN 34.2B | PLN 454.9B | PLN 189.45 | 0.86% down | 4% down | ||
| 7 | Eli LillyLLY · Health Care | PLN 29.2B | PLN 4.95T | PLN 5,559.55 | 2.32% down | 35% up | ||
| 8 | AstraZenecaAZN · Health Care | PLN 23B | PLN 1.11T | PLN 718.73 | 1.93% down | 2% up | ||
| 9 | AbbVieABBV · Health Care | PLN 21B | PLN 2.03T | PLN 1,149.95 | 2.33% down | 26% up | ||
| 10 | Vertex PharmaceuticalsVRTX · Health Care | PLN 20.4B | PLN 546.8B | PLN 2,156.88 | 0.42% up | 27% up | ||
| 11 | BeOne MedicinesONC · Health Care | PLN 18.3B | PLN 185.4B | PLN 1,622.73 | 2.34% down | 17% up | ||
| 12 | GSKGSK · Health Care | PLN 18.1B | PLN 391.5B | PLN 195.32 | 1.34% down | 6% up | ||
| 13 | Novo NordiskNVO · Health Care | PLN 15.8B | PLN 698.7B | PLN 158.53 | 3.12% down | 17% down | ||
| 14 | Takeda PharmaceuticalTAK · Health Care | PLN 15B | PLN 273.2B | PLN 85.52 | 1.71% down | 54% up | ||
| 15 | Teva Pharmaceutical IndustriesTEVA · Health Care | PLN 14.3B | PLN 198.1B | PLN 169.79 | 0.92% down | 74% up | ||
| 16 | Regeneron PharmaceuticalsREGN · Health Care | PLN 12.5B | PLN 393.3B | PLN 3,801.65 | 1.28% down | 36% up | ||
| 17 | ZoetisZTS · Health Care | PLN 9.3B | PLN 139.8B | PLN 344.05 | 2.50% up | 29% down | ||
| 18 | GenmabGMAB · Health Care | PLN 6.9B | PLN 126.4B | PLN 204.93 | 1.91% down | 70% up | ||
| 19 | Alnylam PharmaceuticalsALNY · Health Care | PLN 6.7B | PLN 80.5B | PLN 600.69 | 4.54% down | 66% down | ||
| 20 | United TherapeuticsUTHR · Health Care | PLN 6.3B | PLN 98.9B | PLN 2,321.28 | 1.16% down | 23% up | ||
| 21 | Roivant SciencesROIV · Health Care | PLN 5.7B | PLN 112.8B | PLN 155.72 | 0.05% up | 90% up | ||
| 22 | Jazz PharmaceuticalsJAZZ · Health Care | PLN 5.6B | PLN 63.9B | PLN 996.20 | 2.93% up | 37% up | ||
| 23 | ViatrisVTRS · Health Care | PLN 5.3B | PLN 93.5B | PLN 81.54 | 0.83% down | 96% up | ||
| 24 | BioMarin PharmaceuticalBMRN · Health Care | PLN 5.3B | PLN 47.8B | PLN 246.99 | 4.99% up | 11% up | ||
| 25 | PfizerPFE · Health Care | PLN 4.6B | PLN 643.1B | PLN 112.82 | 1.44% down | 14% up | ||
| 26 | PTC TherapeuticsPTCT · Health Care | PLN 4B | PLN 20.2B | PLN 242.16 | 0.22% down | 20% down | ||
| 27 | GrifolsGRFS · Health Care | PLN 3.7B | PLN 23.2B | PLN 34.05 | 1.85% down | 1% up | ||
| 28 | Legend BiotechLEGN · Health Care | PLN 3.6B | PLN 12.7B | PLN 65.34 | 0.87% up | 42% down | ||
| 29 | Ascendis PharmaASND · Health Care | PLN 2.7B | PLN 71.3B | PLN 1,086.90 | 0.32% down | 28% up | ||
| 30 | Royalty PharmaRPRX · Health Care | PLN 2.5B | PLN 158.8B | PLN 276.10 | 0.01% down | 78% up | ||
| 31 | ABIVAXABVX · Health Care | PLN 2.3B | PLN 29.5B | PLN 337.05 | 2.11% up | 27% down | ||
| 32 | BridgeBio PharmaBBIO · Health Care | PLN 2.3B | PLN 61.1B | PLN 313.65 | 1.58% up | 17% up | ||
| 33 | Elanco Animal HealthELAN · Health Care | PLN 2.2B | PLN 53.7B | PLN 107.35 | 3.29% up | 20% up | ||
| 34 | InsmedINSM · Health Care | PLN 2.1B | PLN 105.7B | PLN 481.67 | 1.69% down | 40% down | ||
| 35 | AlkermesALKS · Health Care | PLN 1.6B | PLN 31.7B | PLN 188.37 | 3.08% up | 58% up | ||
| 36 | Ionis PharmaceuticalsIONS · Health Care | PLN 1.5B | PLN 18.3B | PLN 110.13 | 1.59% up | 64% down | ||
| 37 | Praxis Precision MedicinesPRAX · Health Care | PLN 1.4B | PLN 34.3B | PLN 1,227.06 | 0.04% up | 61% up | ||
| 38 | Belite BioBLTE · Health Care | PLN 1.4B | PLN 25.5B | PLN 628.15 | 0.94% down | 31% up | ||
| 39 | Axsome TherapeuticsAXSM · Health Care | PLN 1.3B | PLN 28.3B | PLN 538.77 | 1.43% down | 7% down | ||
| 40 | Cogent BiosciencesCOGT · Health Care | PLN 1.3B | PLN 19.5B | PLN 111.81 | 0.14% down | 20% down | ||
| 41 | Mirum PharmaceuticalsMIRM · Health Care | PLN 1.2B | PLN 24.3B | PLN 371.87 | 0.59% up | 31% up | ||
| 42 | Amneal PharmaceuticalsAMRX · Health Care | PLN 1.1B | PLN 30.7B | PLN 87.97 | 3.60% up | 83% up | ||
| 43 | Definium TherapeuticsDFTX · Health Care | PLN 1B | PLN 16B | PLN 117.08 | 0.88% down | 169% up | ||
| 44 | Arrowhead PharmaceuticalsARWR · Health Care | PLN 910.9M | PLN 24.5B | PLN 173.33 | 0.28% up | 10% up | ||
| 45 | Summit TherapeuticsSMMT · Health Care | PLN 905.7M | PLN 33.8B | PLN 42.22 | 1.59% down | 36% down | ||
| 46 | Madrigal PharmaceuticalsMDGL · Health Care | PLN 798.9M | PLN 37.2B | PLN 1,600.54 | 5.67% down | 24% down | ||
| 47 | Ligand PharmaceuticalsLGND · Health Care | PLN 703.3M | PLN 24B | PLN 1,201.01 | 1.67% up | 43% up | ||
| 48 | Kiniksa Pharmaceuticals InternationalKNSA · Health Care | PLN 665.8M | PLN 30B | PLN 382.16 | 0.06% down | 126% up | ||
| 49 | Dr. Reddy's LaboratoriesRDY · Health Care | PLN 657.5M | PLN 50.2B | PLN 60.23 | 1.28% up | 5% up | ||
| 50 | Protagonist TherapeuticsPTGX · Health Care | PLN 516.2M | PLN 33.4B | PLN 511.27 | 2.00% up | 46% up | ||
| 51 | CytokineticsCYTK · Health Care | PLN 492.6M | PLN 28.7B | PLN 206.34 | 0.64% down | 20% down | ||
| 52 | Corcept TherapeuticsCORT · Health Care | PLN 484.5M | PLN 29.8B | PLN 272.56 | 3.25% down | 8% down | ||
| 53 | Travere TherapeuticsTVTX · Health Care | PLN 374.1M | PLN 19.4B | PLN 202.00 | 1.68% down | 44% up | ||
| 54 | Spyre TherapeuticsSYRE · Health Care | PLN 344.7M | PLN 38.7B | PLN 407.94 | 8.15% up | 286% up | ||
| 55 | TG TherapeuticsTGTX · Health Care | PLN 318.2M | PLN 40.2B | PLN 265.85 | 5.44% up | 107% up | ||
| 56 | ErascaERAS · Health Care | PLN 296.7M | PLN 19.4B | PLN 55.32 | 0.94% down | 403% up | ||
| 57 | Edgewise TherapeuticsEWTX · Health Care | PLN 245.9M | PLN 18.2B | PLN 166.33 | 1.59% down | 88% up | ||
| 58 | Rhythm PharmaceuticalsRYTM · Health Care | PLN 218.3M | PLN 33.2B | PLN 478.62 | 2.08% up | 13% up | ||
| 59 | Dianthus TherapeuticsDNTH · Health Care | PLN 205.4M | PLN 19B | PLN 337.65 | 3.45% down | 113% up | ||
| 60 | Oruka TherapeuticsORKA · Health Care | PLN 188.7M | PLN 26.1B | PLN 384.94 | 0.60% down | 241% up | ||
| 61 | VeradermicsMANE · Health Care | PLN 87.5M | PLN 21.2B | PLN 502.02 | 0.62% down | 233% up |
Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration; annual figures from the reports companies file with the SEC.
Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Cash on hand is from each company's latest annual report filed with the SEC (collected 2026-11-12); a company that reports in another currency is converted to US dollars at the exchange rate of that day, not of the period. Sums are converted from US dollars at today's exchange rate (1 USD = 4.0206 PLN).
Questions and answers
Which pharmaceutical companies rank first by cash on hand?
Johnson & Johnson (PLN 79.2B), Merck & Co (PLN 58.6B) and Novartis (PLN 46B) are the top three of the 61 pharmaceutical companies ranked by cash on hand as of 19 Nov 2026, 00:41 UTC.
How many pharmaceutical companies are in this ranking?
61 are ranked by cash on hand.
What are these pharmaceutical companies worth together?
The 61 pharmaceutical companies ranked by cash on hand have a combined market value of PLN 20.34T as of 19 Nov 2026, 00:41 UTC.
What does ranking by cash on hand measure?
Cash and cash equivalents at the end of the latest fiscal year. Short-term investments are not counted.
Learn how this ranking works
All markets guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- How an ETF's size is measured: AUM, NAV and creation units
An ETF's size is usually measured by its assets under management (AUM), the fund's net assets: everything it holds minus what it owes. That equals net asset value per share times shares outstanding. AUM grows when the holdings rise in value and when large institutions create new shares, and shrinks when they redeem them.
Cite this page
Funkfolio, “Largest pharmaceutical companies by cash on hand”, data as of 19 November 2026. https://funkfolio.com/companies/category/pharmaceuticals?by=cash-on-hand
Underlying data: Yahoo Finance; SEC EDGAR.